We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Researchers uncover that ketamine’s antidepressant results contain the mind’s opioid system
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > Researchers uncover that ketamine’s antidepressant results contain the mind’s opioid system
Researchers uncover that ketamine’s antidepressant results contain the mind’s opioid system
Health

Researchers uncover that ketamine’s antidepressant results contain the mind’s opioid system

Last updated: July 24, 2025 10:28 am
Editorial Board Published July 24, 2025
Share
SHARE

1H-fMRS voxel place and spectra. a, Voxel middle placement. b, Voxel density map throughout members and periods in Montreal Neurological Institute (MNI) house. Credit score: Nature Drugs (2025). DOI: 10.1038/s41591-025-03800-w

Ketamine is a extremely efficient, fast-acting antidepressant that works even for sufferers who haven’t responded to different medicines. Nevertheless, the mind mechanisms necessary for these fast remedy results are but to be decided.

Researchers at King’s School London, who’re investigating why ketamine could possibly be a superb remedy for some folks with melancholy, have found that the drug’s antidepressant results contain the mind’s opioid system.

The research, led by King’s School London and printed in Nature Drugs, included 26 people with clinically recognized melancholy who got a low-dose ketamine infusion throughout two periods throughout neuroimaging.

Earlier than receiving the ketamine infusion, in a single session they got naltrexone, which blocks the opioid receptors within the mind, and within the different they got a placebo.

Individuals had been monitored throughout the infusion in a mind scanner utilizing a way referred to as magnetic resonance spectroscopy (MRS). MRS measured dynamic adjustments in a mind chemical referred to as glutamate.

Depressive signs had been then assessed utilizing the clinician-rated Montgomery-Åsberg Melancholy Score Scale (MADRS) 24-hours after infusion, when ketamine’s antidepressive signs peak.

They discovered that blocking the opioid system diminished each the mind’s glutamatergic response and the antidepressant results noticed the next day, suggesting that the opioid system performs a key position in mediating the antidepressant response.

The research additionally recognized a sex-related impact: the impact of naltrexone on glutamatergic exercise appeared extra pronounced in males with melancholy than in females with melancholy.

These insights into how ketamine works for various persons are important to personalizing therapies.

“Understanding whether the opioid system is involved in ketamine’s antidepressant effects is a really important question, given how much we still don’t know about how ketamine works. Our study shows that the opioid system is involved and offers insight into how it contributes to ketamine’s effects.”

The authors are eager to focus on that ketamine shouldn’t be labeled as an opioid and doesn’t bind to opioid receptors with excessive affinity like morphine or heroin. As a substitute, the findings level to a dynamic interaction between the glutamatergic and opioid techniques, which can work collectively to help ketamine’s fast antidepressant results.

Opiates can supply aid from the system of melancholy, nonetheless, they’re extremely addictive. Understanding if and the way the opioid system is concerned within the results of ketamine is necessary to grasp why ketamine works, and for growing new, different therapies.

Low-dose ketamine is presently getting used to deal with melancholy in non-public clinics and a small variety of NHS clinics. At greater doses, it is usually utilized in medicinal anesthesia. Nevertheless, it is usually used recreationally and, if misused, could cause critical well being issues, together with irreversible injury to the bladder and kidneys.

Professor Mitul Mehta, a professor of neuroimaging and psychopharmacology at King’s School London, mentioned, “The brain’s different neurochemical systems work together to produce our experiences and behavior, so it is no surprise that the opiate system may have a role in ketamine’s antidepressant effect.”

“We need these kinds of studies to understand exactly what the important brain mechanisms are for antidepressant effects. Understanding more about how ketamine works can lead to treatment being personalized for different people, which is vital for creating safe and effective treatments.”

Extra info:
Luke A. Jelen et al, Impact of naltrexone pretreatment on ketamine-induced glutamatergic exercise and signs of melancholy: a randomized crossover research, Nature Drugs (2025). DOI: 10.1038/s41591-025-03800-w

Supplied by
King’s School London

Quotation:
Researchers uncover that ketamine’s antidepressant results contain the mind’s opioid system (2025, July 24)
retrieved 24 July 2025
from https://medicalxpress.com/information/2025-07-ketamine-antidepressant-effects-involve-brain.html

This doc is topic to copyright. Other than any honest dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is offered for info functions solely.

You Might Also Like

Psilocybin may reverse results of mind accidents ensuing from intimate associate violence, rat research finds

Predicting illness outbreaks utilizing social media

Deep mind stimulation succeeds for 1 in 2 sufferers with treatment-resistant extreme melancholy and nervousness in trial

Australian drug driving deaths have surpassed drunk driving. Here is the way to deal with it

Tooth of infants of confused moms come out earlier, suggests examine

TAGGED:antidepressantbrainsdiscovereffectsinvolveketaminesopioidResearcherssystem
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
Olympics broadcast middle and film studio coming to Hollywood Park
Entertainment

Olympics broadcast middle and film studio coming to Hollywood Park

Editorial Board May 13, 2025
Yeshiva’s Ryan Turell Leads College Basketball in Scoring
Nassar Abuse Survivors Reach a $380 Million Settlement
Q&A: How can drug repurposing decrease drug prices and enhance care?
Images That Depict Alzheimer’s With Dignity

You Might Also Like

New malaria drug heralds resistance breakthrough
Health

New malaria drug heralds resistance breakthrough

November 18, 2025
Chasing a successful streak: A brand new approach to set off responses within the physique by simulating psychological strain
Health

Chasing a successful streak: A brand new approach to set off responses within the physique by simulating psychological strain

November 18, 2025
The worldwide system for assessing organ dysfunction in critically sick sufferers is up to date after thirty years
Health

The worldwide system for assessing organ dysfunction in critically sick sufferers is up to date after thirty years

November 18, 2025
Breast most cancers remedies can enhance each survival probabilities and revenue
Health

Breast most cancers remedies can enhance each survival probabilities and revenue

November 18, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • Art
  • World

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?